Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials

Bambusa Therapeutics filed for an IPO to fund trials of its drugs to treat eczema and other inflammation disorders.

This news has no direct impact on seafarers, as it pertains to the pharmaceutical industry rather than maritime or shipping news.